Partial validation of the chromato-mass-spectrometric methodology for the determination of carbon sulfur in infusion medicines

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Relevance. Nowadays the standardization and control of medicines to provide the consumer with high-quality pharmaceutical products is an important issue. The use of parenteral medicines is associated with the potential risk of exposure to the patient's body of carbon disulfide, which is contained in rubber plugs and can pose a serious health hazard.

The purpose of this article is to conduct partial validation of the developed methodology for quantification of carbon disulfide impurities in infusion dosage forms by chromato-mass spectrometry.

Material and methods. The model solution was the drug "Reopoliglyukin, solution for infusion" (JSC BIOCHEMIK, Russia). Methyl ethyl sulfide, 99% (NevaReaktiv, Russia) was used as an internal standard. The measurements were carried out on a chromatography-mass spectrometer model GCMS-QP2010 Ultra, manufactured by Shimadzu, Japan.

 

Results. The process of sample preparation is described, also the acceptance criteria for determining specificity, linearity, accuracy and limit of quantification were set. The chromatograms and results obtained for the model sample "Rheopolyglucin, solution for infusion" are presented, the coincidence of the peak areas in terms of retention times for the model sample and carbon disulfide, as well as the internal standard, allows us to state that the method meets the requirements for the "Specificity" indicator. The necessary calculations were made to confirm that the analytical methodology is linear. The limit of quantitation was found experimentally by means of a series of dilutions. The correctness was confirmed using the method of additions.

Conclusion. The measures taken made it possible to carry out a partial validation of the analytical methodology for determining carbon disulfide impurities in infusion drugs. It has been determined that all the results obtained meet the indicated acceptance criteria within the selected range of characteristics. Also, it was confirmed that in the indicated concentrations, the methodology has no system error.

Full Text

Restricted Access

About the authors

O. A. Selyutin

ITCT named after M.V. Lomonosov, MIREA - Russian Technological University; Voronezh Regional Clinical Oncological Dispensary

Author for correspondence.
Email: selutinoa@yandex.ru

Applicant, Department of Biotechnology and Industrial Pharmacy; Deputy Chief Physician for Clinical Research and Innovative Technologies

Russian Federation, Moscow; Voronezh

D. O. Shatalov

ITCT named after M.V. Lomonosov, MIREA – Russian Technological University; Institute of Pharmaceutical Technologies JSC

Email: shat-05@mail.ru

Ph.D. (Pharm.), Associate Professor of the Department of Biotechnology and Industrial Pharmacy; Deputy General Director

Russian Federation, Moscow; Moscow

D. I. Pisarev

People's Friendship University of Russia

Email: juniper05@mail.ru

Dr.Sc. (Pharm.), Associate Professor, Professor of the Agrarian and Technological Institute

Russian Federation, Moscow

O. O. Novikov

Peoples' Friendship University

Email: ole9222@yandex.ru

Dr.Sc. (Pharm.), Professor, Deputy Director for Scientific and Educational Work, NORC Pharmacy

Russian Federation, Moscow

E. T. Zhilyakova

Belgorod State National Research University

Email: ezhilyakova@bsu.edu.ru

Dr.Sc. (Pharm.), Professor, Head of the Department of Pharmaceutical Technology

Russian Federation, Belgorod

V. V. Chichulina

ITCT. M.V. Lomonosov, Russian Technological University

Email: murzilka991@gmail.com

Student, Department of Biotechnology and Industrial Pharmacy

Russian Federation, Moscow

A. I. Gromakova

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: a_gromakova@mail.ru

Dr.Sc. (Pharm.), Chief Research Scientist, the Scientific and Organizational Department

Russian Federation, Moscow

V. N. Davydova

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: davydova.vn@gmail.com

Dr.Sc. (Pharm.), Chief Research Scientist

Russian Federation, Moscow

N. V. Sahno

Oryol state agrarian University named after N.V. Parakhina

Email: sahnoorelsau@mail.ru

Dr.Sc. (Veterinary), Professor of the Department Epizootology and therapy

Russian Federation, Oryol

References

  1. Astrafarm. Jelektronnyj resurs: http://www.astra-farm.ru/ katalog.htm (Data obrashhenija – 10.04.2021).
  2. Бырько В.М. Дитиокарбаматы Электронный ресурс: https://www.studmed.ru/byrko-v-m-ditiokarbamaty_4b9d51d56 65.html (Data obrashhenija – 11.05.2021).
  3. Grushko Ja.M. Vrednye organicheskie soedinenija v promyshlennyh vybrosah v atmosferu. Jelektronnyj resurs: https://www.airsoft-bit.ru/pervichnye-pokazateli-opas-nosti/347-grushko-vrednie-orgsordinenia-v-prom-stochnix-vodax-1982 (Data obrashhenija – 22.02.2022).
  4. Guzhova S.V., Simonova N.N., Liakumovich A.G., Sharafutdinova D.R., Holin K.V., Fatkullina A.F. Sanitarno-himicheskie issledovanija mnogokomponentnogo sostava veshhestv, migrirujushhih iz rezinovyh medicinskih probok na osnove butilkauchukov. Vestnik Roszdravnadzora. 2013; 5: 44-49.
  5. Guzhova S.V. Termojelastoplastichnyj material dlja probok farmacevticheskogo naznachenija: Avtoref. diss. kand. tehnicheskih nauk. Kazan', 2017. 20.
  6. Seljutin O.A. Razrabotka original'noj metodiki opredelenija serougleroda v infuzionnyh lekarstvennyh preparatah. Nauchnye rezul'taty biomedicinskih issledovanij. 2018; 4 (1): 88-98.
  7. Federal'nyj zakon «Ob obrashhenii lekarstvennyh sredstv» ot 12.04.2010 N 61-FZ.
  8. Gosudarstvennaja farmakopeja XIV. OFS.1.1.0012.15 Validacija analiticheskih metodik.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1

Download (30KB)
3. Fig. 2

Download (10KB)
4. Fig. 3

Download (22KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies